Investment
Features
FeesSafety
Academy
More
Pluang+

Compare New Era Energy & Digital Inc. Common Stock (NUAI) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

New Era Energy & Digital Inc. Common StockTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

New Era Energy & Digital Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? New Era Energy & Digital Inc. Common Stock trades at $4.72 (market cap $583.45M), while Revolution Medicines Inc. Common Stock trades at $191.29 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 69.1× New Era Energy & Digital Inc. Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, New Era Energy & Digital Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold New Era Energy & Digital Inc. Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

NUAIRVMD
Market Cap
$583.45M$40.32B
Volume
17,217,4124,855,734
Sector
TechnologyHealth
52-Week High
$8.06$221.15
52-Week Low
$2.35$47.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$528.80M$37.02B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUAI
100% Buy0% Sell
Avg holding period · 0 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.

Read more on NUAI →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →